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The Global Burden of Disease (GBD) framework was jointly devel-
oped by the WHO, the World Bank and the Harvard School of Public
Health in the early 1990s with the aim to permit a first comprehen-
sive and comparable evaluation of population health for all countries
of the world [1]. The possibility to compare disease burden over time
and between countries provides valuable insights into intervention
successes, failures as well as unfinished agendas and can also high-
light emerging health threats. Since the first GBD analyses several
updates of the GBD study were performed by the WHO.
The Institute for Health Metrics and Evaluation (IHME) has recently
presented a fully refreshed set of global disease burden estimates
and aims for updates on a regular basis [2]. To provide information
that is useful to guide public health policy decision-making processes
at the national level, IHME researchers, WHO and public health re-
searchers from individual countries need to intensify their dialogue
on research demands, the necessary methods, and the quality of the
underlying data used for such assessments. To this effect, WHO and
IHME recently signed a memorandum of understanding for en-
hanced collaboration and data sharing.
The international workshop “From Global Burden of Disease Studies
to National Burden of Disease Surveillance” aimed to enhance the co-
operation in public health research and exchange of information be-
tween researchers of the GBD study and public health and
environmental health institutes in Germany. The framework, method-
ology and results from recent international and national GBD ana-
lyses were presented by researchers from the IHME and Public
Health England. The Workshop was organized by the Department of
Epidemiology and Health Monitoring at Germany’s Robert Koch Insti-
tute (RKI) and the German Environment Agency (UBA) in cooperation
with the German Society for Epidemiology (DGEpi) e.V. and Bielefeld
University.
Maria Krautzberger, president of the UBA and Prof. Dr. Lothar Wieler,
president of the RKI emphasized in their welcome addresses the im-
portance for a strong collaboration on burden of disease analyses be-
tween the WHO, the IHME, and the public health research network in
Germany including RKI, UBA as well as representatives from various
public health and epidemiology departments and professional
societies.
During two days, a team of scientists from international and German
public organizations discussed GBD methods and results as well as
strategies for national burden of disease analyses with an audience© 2016 The Author(s). Open Access This artic
International License (http://creativecommons
reproduction in any medium, provided you g
the Creative Commons license, and indicate if
(http://creativecommons.org/publicdomain/zeof over 60 attendees. In total, 8 presentations followed by intensive
discussions were delivered.
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The Global Burden of Disease (GBD) quantifies and compares health
loss due to diseases, injuries, and risk factors by age, sex, and geog-
raphy over time. The latest iteration of the GBD 2013, was published in
The Lancet in 2014 and 2015 [1-4]. As a global public good, GBD is use-
ful for informing the design of health systems and the creation of pub-
lic health policy. It estimates premature death and disability due to 306
diseases and injuries, 2,337 sequelae, and 79 risk factors by age and sex
for 1990, 1995, 2000, 2005, 2010, and 2013. GBD 2013 produced esti-
mates for 188 countries. This is a collaborative effort among more than
1,500 researchers from 120 countries, and the Institute for Health Met-
rics and Evaluation (IHME) is the coordinating center for the study.
The first GBD study was published as part of the World Development
Report 1993. The authors’ inspiration for the study came from realiz-
ing that policymakers lacked sound, comprehensive, and standard-
ized data on diseases, injuries, and potentially preventable risk
factors for decision-making. The GBD 1990 study had a profound im-
pact on health policy as it exposed the hidden burden of mental ill-
ness around the world and shed light on neglected health areas
such as road traffic injuries.
According to GBD 2013 results, life expectancy in Germany increased
by 4.6 years for females and 6.2 years for males between 1990 and
2013. Low back and neck pain was the leading cause of disability-
adjusted life years (DALYs), with ischemic heart disease and stroke
being the second- and third-leading causes, respectively. Disability-
adjusted life years include health loss due to premature death and
disability. Total DALYs from both ischemic heart disease and strokele is distributed under the terms of the Creative Commons Attribution 4.0
.org/licenses/by/4.0/), which permits unrestricted use, distribution, and
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factor for DALYs in 2013 was dietary risks, accounting for more than
25 % of total DALYs. High systolic blood pressure and high body
mass index were the second- and third-leading risk factors for DALYs
in 2013, respectively. Benchmarking Germany’s performance for lead-
ing causes of premature death against peer countries reveals that
Germany performed significantly worse for ischemic heart disease
but significantly better for chronic obstructive pulmonary disease
and road injuries. Considering that aggregate estimates often con-
ceal important subnational differences, collaborative efforts towards
understanding the subnational burden of disease, would be more
useful for Germany policy making.
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The Global Burden of Diseases, Injuries and Risk Factors study 2013
(GBD) is the second update to a series of studies initiated by the
World Bank, the Harvard School of Public Health and WHO in the
1990s. The main aims of the first GBD study were to present the
health status of the global population and to introduce a method-
ology for a comprehensive and comparable assessment of the global
disease burden including all relevant entities causing ill-health. The
first GBD assessment highlighted the importance of mental condi-
tions and injuries for the global health status and the recent updates
strongly emphasized the impact of the global epidemiological and
demographic transition on population health. One of the central
measures introduced by the GBD framework is the Disability-
Adjusted Life Year (DALY) which estimates healthy life years lost due
to the effects of mortality and morbidity. This measure allows the
quantification of health losses comparable between different health
conditions, population groups and over time. The current GBD as-
sessments include four major groups of efforts including: 1) estimating
all-cause mortality and life expectancy, 2) cause-specific mortality, 3)
morbidity and disability weight estimation, and 4) covariates and risk
factor burden estimation. The GBD 2013 involved the collection and
analysis of global health data to estimate the burden of diseases mea-
sured by DALY and life expectancy as well as healthy life expectancy
(HALE) for 188 countries, China, Mexico and UK subnational areas, for
20 age-groups, both sexes, and for each 5 year interval for the years
1990 – 2010 and for 2013 [1]. Different data sources as well as cause-
and risk-specific methods and analytical tools were employed to deal
with data scarcity and estimate the health outcomes and risk factor
burden. The governance model for GBD is designed to incorporate the
expertise of more than 1500 collaborators. The GBD is strengthened by
a rich scientific team, a strong computational infrastructure and
visualization experts, as well as teams specializing in disseminating andengaging policy-makers, government agencies, and others in the
use of the results. In this presentation different GBD 2013 sec-
tions, outcome measures, causes as well as the structure of se-
quelae and risk factor estimation are explained. Further, major
methods such as CODEm [2], DisMod-MR and challenges such as
garbage code redistribution and risk factor aggregation were dis-
cussed. The presentation also gave an introduction to the GBD
visualization tool-suite [3].
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The England Burden of Disease programme builds upon the GBD
(Global Burden of Disease) experience in order to
 present an England as opposed to a UK perspective
 provide quality assurance of English data used while exercising
version control
 allow a subnational breakdown of analysis
 investigate links between risk factors, deprivation, geography,
and outcomes
Data going back up to 20 years were provided to the Institute for
Health Metrics and Evaluation on mortality, morbidity and risk fac-
tors. These were broken down by nine English regions, correspond-
ing to the former Government Office Regions in England. The Index
of Multiple Deprivation (IMD-2010) was used, which allocates a pov-
erty score to each LSOA (lower super output area) in each region.
LSOAs are relatively homogeneous areas containing about 1600
people on average. The IMD-2010 is a composite measure estimated
at a small geographical area and includes seven domains: income,
employment, health and disability, education skills and training,
barriers to housing and services, living environment, and crime. Com-
bining information about regions and LSOAs allowed creating 45 re-
gional deprivation areas in total.
Before this exercise no single accessible source describing overall dis-
ease burden by cause existed for England. The subsequent analysis
[1] provides policy-makers with important headline results:
 England performs above average vs other high income
countries on key health outcomes, with life expectancy from
birth increased by more than 5 years between 1990 and 2013
 Gains are greater for men than for women
 Large improvements in rates of premature mortality but not in
morbidity means living longer but spending more years in ill-health
 Health inequalities (in life expectancy but also in prevalence of
preventable diseases) persist, largely driven by deprivation;
important within regions as well as between regions
 40 % of ill health in England is due to potentially preventable
risk factors, with unhealthy diet and tobacco being the two
biggest risks. This compares unfavourably with the funding
provided for prevention.
Current discussions about the future application of the GBD method-
ology in England examine its use in surveillance, in particular
BMC Proceedings 2016, Volume 10 Suppl 5 Page 55 of 57 as part of the standard suite of tools developed by Public
Health England
 for provision of estimates at local level as opposed to national
and regional level
 use of GBD outputs as inputs for modelling
 international collaboration with peer countries, especially on
non-communicable diseases
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The global burden of disease methodology developed by Murray
and Lopez [1] has been used by the World Health Organization for
over 20 years. The burden of disease approach is very ‘data hungry’
requiring sex- and age-disaggregated information on deaths and
diseases, with data sources ranging from vital statistics and civil
registration systems, as well as disease registers, hospital discharge
data and surveys examining disease and risk factor prevalence. The
strengths of the burden approach include the development of a
summary measure that combines mortality, morbidity and disabil-
ity, where years of life lost (YLL) are added to years lived with dis-
ability (YLD). It permits the measurement of loss of health in an
internationally comparable way, the de-coupling of advocacy from
epidemiological assessment and the avoiding of double counting.
Numerous countries have conducted national burden of disease
studies but frequently struggle with lack of or fragmentation of
data at the national level (in which case uncertainty analyses are an
important feature), a focus on fatal outcomes and concerns about
the appropriateness of disability weights for their own settings. The
latter can be a serious obstacle, and some countries have embarked
on developing their own disability weights which are seen as more
appropriate for the local context but result in reduced international
comparability between studies. In some instances, the value judg-
ments associated with disability weights as well as potential age-
weighting have even rendered the burden of disease approach as
unacceptable to policy makers. In addition, a tendency to ‘start
with’ or settle for an abbreviated list of causes instead of the full
set of ICD 10 compatible causes is tempting but may lead to
skewed results and a masking of the actual burden in the country.
In addition, adjustments for co-morbidity are not currently made
and the need to allocate one single cause of death is perceived by
some as not ‘based in reality’; while this issue remains unresolved,
some countries have shied away from the burden approach
altogether. The presentation at the workshop discusses these issues
and proposes some ways forward for countries wishing to conduct
full burden of disease studies. The author calls for the development
of a practical manual for national burden of disease studies to
guide countries in conducting their national studies by preserving
international comparability while at the same time allowing to re-
spect the local context.
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As a country in an advanced stage of demographic and epidemio-
logical transition, Germany faces an increasing burden of non-
communicable diseases and age-related health conditions [1]. A pub-
lic health approach to effective health promotion and prevention at
all stages of life is needed to delay age-related degenerative diseases
and functional decline. While average life expectancy has continu-
ously increased for both sexes in Germany over the past decades,
Germany ranks well behind several other European countries. This is
especially true for disability-free life expectancy, expressed as the
number of remaining years an individual can expect to live without
any disability at a defined age (Healthy Life Years indicator). There
are large regional differences in life expectancy and in the preva-
lence of non-communicable diseases and associated risk factors in
Germany. These differences are highly correlated with both individ-
ual- and area-level socioeconomic differences [2].
To deliver guidance to health politicians and health care providers,
Germany is in need of strong public health information systems that per-
mit continuous monitoring of disease burden and the driving causes, in-
cluding socioeconomic context variables, environmental and behavioral
risk factors, and joint risk profiles. In 2008 the Federal Ministry of Health
Germany commissioned the Robert Koch Institute to establish a continu-
ous health monitoring system at the national level based on repeated
cross-sectional health surveys and a national cohort study of children and
adolescents [3-4]. Furthermore, the Centre for Cancer Registry Data (ZfKD)
was established at the Robert Koch Institute in 2010, allowing continuous
monitoring of time trends in site-specific cancer incidence and mortality
based on pooled data from regional population-based cancer registries
[5]. A major goal is to further strengthen the national health indicator
database by including timely information obtained from sustainable
sources of routine health care data, e. g. statutory health insurance data.
National burden of disease analyses based on the Disability-Adjusted
Life Year (DALY), a summary measure of population health, may prove
useful for public health goal and priority setting. However, this largely
depends on the quality and availability of input data. Harmonizing data
collection, analysis and interpretation at the national and sub-national
level remains a major issue in Germany. A pilot project is currently un-
derway and will focus on improved diabetes surveillance. It will also be
necessary to validate disability weights in national health surveys con-
sidering not only individual disease states, but also multimorbidity,
states of critical functional impairment, potentially inappropriate medi-
cation, and avoidable hospital admissions.
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Outcome-Trees as a first step to estimate the burden of Healthcare
Associated Infections
Assessing the burden of Healthcare Associated Infections (HAI) is
challenging. So far published estimates do not fully disclose the ac-
tual burden of disease. Outcome-trees with transitional probabilities
for mortality and sequelae adjusted for comorbidities were devel-
oped to allow disability-adjusted life years (DALY) calculations in an
incidence based approach.
Selected HAI (urinary tract infection, primary blood stream infection
(neonatal and non -neonatal sepsis [1]), Clostridium difficile infection,
pneumonia and lower respiratory tract infections, surgical site infection
(joint replacement (hip and knee), coronary artery bypass graft)) were
used. Further, results of systematic reviews were included to develop
disease specific outcome trees. They reflect the attributable intensive
care unit length of stay inclusive of short term complications, attribut-
able mortality and long term complication such as cognitive impair-
ment, posttraumatic stress disease, physical impairment, and chronic
renal failure. A protocol was developed to calculate evidence based
transitional probabilities adjusted for comorbidities and attributable
mortality for HAIs. To calculate the DALYs incidence data may now be
entered into the model. So far the role of HAIs is underestimated in
GBD and thus also the actual burden of infectious diseases.
Using non-specific data to estimate the specific burden of disease
of influenza in Germany
The Burden of Communicable Diseases in Europe (BCoDE) project de-
veloped a methodology called the pathogen- and incidence-based ap-
proach to estimate the burden of infectious diseases [2]. For influenza
in Germany, multiplication factors and the burden to be estimated may
vary substantially from year to year. Therefore, an alternative approach
was developed, estimating the year-specific burden (impact of influ-
enza on each level of the clinical outcome/provider pyramid) based on
year-specific data. Sensitive syndromic indicators (e.g. acute respiratory
infections, hospitalization due to any respiratory disease and mortality
due to any cause) will be included.
The weekly number of confirmed influenza specimens was used as a
proxy variable for the season specific course of influenza inside a
generalized additive model to reconstruct the course of medically
attended acute respiratory infections (MAARI) in Germany. From the
same data the type/subtype distribution was inferred to estimate a
(sub) type specific number of MAARI infections associated to influ-
enza. First results show that the amount of acute respiratory infec-
tions in primary care could be estimated reliably. The approach to
estimate/model the burden of influenza on a yearly basis from sur-
veillance and health system data seems feasible and should provide
trustworthy and comprehensive year-specific estimates.
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Knowing the overall burden of disease, it is also important to identify
which risk factors can be made responsible and where intervention and
prevention measures can help to reduce the burden. Risk factor burden
estimation directly informs policy makers how to control the burden of
diseases in different countries based on the national or, if available,
local risk profiles. Environmental and behavioral risk factors cause dis-
eases either directly or through mediated risks such as metabolic risks,
for example high systolic blood pressure, high cholesterol and high
fasting plasma glucose. This presentation focuses on some environmen-
tal and behavioral risks factors that are more relevant to developed
countries, including Germany. Data sources for estimating the exposure
of risk factors, the disease outcomes of the risk factors and effect sizes
were discussed and the methods of exposure estimation for several
risks was explained (ambient particulate matter pollution, hand wash-
ing, smoking and second hand smoke, diet (14 individual risks including
sodium), alcohol consumption, drug use, low physical activity, unsafe
sex, childhood sexual abuse, interpersonal violence, and occupational
risk factors). Some specific aspects such as risk factor aggregation and
mediation are also discussed briefly [1]. In general, the risk factors cov-
ered by the GBD-Study were selected based on their relevance for the
global population. Nonetheless, countries may have specific risk factor
profiles requiring to consider additional risk factors. It can therefore be
recommended to conduct national assessments of the disease burden
including risk factors that are of importance for specific countries. The
current results of the GBD 2013 assessment clearly show, that about
60 % of the overall disease burden measured in DALYs cannot be at-
tributed to any risk factor covered by the GBD study. This however,
shows the general need to increase the scope of risk factors. An inclu-
sion of further evidence on risk-outcome-pairs may enable further pos-
sibilities to foster measures to further decrease the disease burden.
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The EBD concept is increasingly used by international and national in-
stitutions to identify key environmental drivers of ill-health. In Germany,
especially the German Environment Agency funded and carried out re-
search projects to test the feasibility of the EBD methods on a national
scale, quantify the EBD and to evaluate the scientific, legal and ethical
challenges introduced with the use of this concept. Air pollution, more
specifically particulate matter in ambient air, was identified as the haz-
ard by far causing the highest burden in Germany. A time-series ana-
lysis starting in 2007 shows that despite a downward trend, particulate
matter pollution in 2013 is still linked to about 43,500 premature
deaths and 312,000 years of life lost [1]. Further, second-hand-smoke,
residential radon, dioxins, environmental noise, ozone and lead were
identified as important contributors to the EBD in Germany [2-3]. How-
ever, one might overlook further important hazards where scientific
BMC Proceedings 2016, Volume 10 Suppl 5 Page 57 of 57evidence is hampered by uncertainty with regard to the causal link be-
tween hazards and health outcomes [4].
Another important stumbling block are the disability weights, which
are not available for some health effects caused by environmental
hazards and despite the claimed transferability of the GBD-weights
to other countries, the discussion on disability weights is still on-
going in Germany.
According to the Agency’s commitment to the precautionary
principle, there is not only the need for cross-sectional and retro-
spective analyses of the EBD, but also for prospective forecasts to
shed light on the future burden caused by environmental hazards.
Such analyses require robust baseline estimates and reliable progno-
ses on the epidemiology and demography as well as estimated
changes of the population’s exposure to environmental risk factors.
These aspects will be covered by a research project, focusing on the
EBD in children and adolescents in Germany. As disease burden
caused by environmental hazards often follows long lag-periods this
project is designed to quantify the current and potential future
health burden in a probabilistic framework [5].
Implications for international collaboration
Even though the strength of evidence for some environmental haz-
ards is currently partially limited, assessments should increasingly fac-
tor in hazards of concern such as environmental noise and endocrine
disrupting chemicals. Despite the importance of air pollution, where
data quantity and quality are rapidly increasing, upcoming assess-
ments should also consider new and potential future hazards. In
addition to the work on single hazards, collaborations should further
foster the estimation of combined effects of environmental risk
factors.
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The presentations of the workshop provided deep insights into the
concepts and ideas of the GBD framework. They impressively showed
the potential of this concept to provide a view on the development
of health at the global level as well as at the level of individual coun-
tries and regions within countries. Most of the participants of the
workshop and especially the WHO representative shared the view
that this workshop was a crucial and necessary step for Germany’s
engagement in the GBD network and a promising stimulus for a na-
tional burden of disease study (NBD).
The experience of Public Health England has nicely shown how sub-
national estimates can shed additional light on existing health in-
equalities at the regional level. Much commitment of local authorities
is needed and only a concerted action of national institutions can
lead to a success story in terms of a NBD study. Intense and continu-
ous scientific exchange between German public health experts and
the GBD representatives could help to expand analyses for Germany
and ensure their use for public health policy and practice.
Future research collaborations and the possibility to include burden
of disease estimates into national disease surveillance in Germany
were discussed with respect to international and national challenges
for population health and public health policy.
Overall discussion topics were challenges in the regional variation of
health and health care, including estimates of disease prevalence
and incidence, the proportion between diagnosed and undiagnosed
health conditions. Further, a particular challenge with respect to an
ageing population, turned out to be functional capacities, particularly
how to consider innovations in diagnostic criteria, and the operatio-
nalisation of multimorbidity.
The workshop brought up many ideas of how to improve data col-
lection systems and how use of already available data sources might
help to improve the current estimates. National burden of disease
surveillance is considered being not only a mission, but a dynamic
process with a considerable return on investment and of important
value for public health in Germany.
The next step for Germany is to build up a burden of disease collab-
oration network between universities, institutes and federal as well
as regional ministries. Further, it is also envisaged to create an inter-
national network of countries who already have conducted a national
burden of disease study or who are currently running or planning an
assessment. This network is meant as platform to share and discuss
methods, results and future public health challenges.
